MF houses
Aug 20264no change m/m
Top buyer Bandhan Mutual Fund, +0.34% of equity. Index and arbitrage funds hidden.
AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure)
4 fund houses →
Jubilant Pharmova Limited
₹1,071.95NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: Shareholding pattern as of 30 Jun 2026, filed 21 Jul 2026Pledge: Shareholding pattern as of 30 Jun 2026Insider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
5.03%▲ +0.34 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
15.87%
as of 30 Jun 2026
Fund houses holding
4no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
6.58%
as of 30 Jun 2026
What changed
4 tracked fund houses held JUBLPHARMA in Aug 2026. None entered or exited.
All tracked schemes together held 80.06 lakh shares, 5.03% of equity, worth ₹706 cr at the end of Aug 2026.
Index and arbitrage funds held 0.29% of equity; they are left out of the fund-house counts.
Named FPIs at 1% or more
as of 30 Jun 202615.87%
FPI category I + II, % of total shares · 3 named at 1% or more
FPIs named at 1% or more on 30 Jun 2026: GOVERNMENT PENSION FUND GLOBAL 3.10%; EAST BRIDGE CAPITAL MASTER FUND I LTD 2.53%; Theleme India Master Fund Limited 1.89%.
Shareholding pattern as of 30 Jun 2026, filed 21 Jul 2026Source: NSE shareholding pattern filings (XBRL), quarterly
Insider and promoter
29 Jun 2026 to 26 Sep 2026No insider or promoter trade in JUBLPHARMA was disclosed 29 Jun 2026 to 26 Sep 2026.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)
Bulk and block deals
25 Sep 2026No bulk or block deals in JUBLPHARMA on 25 Sep 2026.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily
Promoter pledge
as of 30 Jun 20266.58%
of promoter holding · 3.14% of total shares
Promoters had pledged 50.00 lakh of their 7.59 cr shares on 30 Jun 2026; 50.00 lakh encumbered in all (pledge, NDU and other).
Shareholding pattern as of 30 Jun 2026Source: NSE shareholding pattern filings (XBRL), quarterly
SLBM borrowing
25 Sep 2026NSE listed no SLBS open position for JUBLPHARMA on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in JUBLPHARMA on 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily
MTF book
24 Sep 20263.02 lakh sh▲ +5,275 vs 23 Sep 2026
percentile 45 of 29 days collected · ₹31.9 cr financed
3.02 lakh shares, 0.19% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 45 of 29 days collected.
NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily
Delivery
25 Sep 202645.4%▲ +0.1 pp vs 20-day average
20-day average 45.4% · percentile 40 of 30 days collected
45.4% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 45.4%; that day sits at percentile 40 of 30 days collected.
NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily
Red flags
25 Sep 2026No F&O
JUBLPHARMA has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed JUBLPHARMA under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.
NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily